CLCR Call: March 8, 2021

For Public Health

At a glance

The March 8, 2021, Clinical Laboratory COVID-19 Response (CLCR) call included updates on SARS-CoV-2 variants and from the FDA and CDC Infectious Diseases Pathology Branch.

Format: MP3
Language: English (US)
Size: 26 MB

Agenda

Archived LOCS Materials Access

Contact LOCS to access archived LOCS materials.

Welcome: Jasmine Chaitram, CDC Division of Laboratory Systems (DLS)

SARS-CoV-2 Variants Update: Vivien Dugan, CDC Laboratory and Testing Task Force for the COVID-19 Response

Updates from the CDC Infectious Diseases Pathology Branch: Julu Bhatnagar, CDC Division of High-Consequence Pathogens and Pathology (DCHPP)

FDA Update: Tim Stenzel, U.S. Food and Drug Administration (FDA)

Meeting materials

Content Source
About this page
Published: November 20, 2024
Updated: March 8, 2021

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: March 8, 2021

The information on this page was last reviewed by subject matter experts to ensure accuracy.